Ranatuerin-2

General Information


DRACP ID  DRACP01058

Peptide Name   Ranatuerin-2

Sequence  GLFLDTLKGAAKDVAGKLEGLKCKITGCKLP

Sequence Length  31

UniProt ID  Not available

PubChem CID  Not available

Origin  Rana catesbeiana

Type  Native peptide

Classification

  

Active ACP



Activity Information


Cell Line Disease Cancer Classified Activity Assay Testing Time Literature
A549 Lung adenocarcinoma Carcinoma IC50>128 µM MTT assay 24h 1
MCF-7 Invasive breast carcinoma of no special type Carcinoma IC50>128 µM MTT assay 24h 1
HeLa Human papillomavirus-related endocervical adenocarcinoma Carcinoma IC50>128 µM MTT assay 24h 1
LoVo Colon adenocarcinoma Carcinoma IC50=128 µM MTT assay 24h 1

Hemolytic Activity  Human erythrocytes: 0% Hemolysis=20 µg/ml; Sheep erythrocytes: <10% Hemolysis=256 µM

Normal (non-cancerous) Cytotoxicity  HEK293T cells: IC50>128 µM

Target  Not available

Affinity  Not available

Mechanism  Not available

Nature  Anticancer; Antibacterial; Antifungal



Structure Information


PDB ID  Not available

Predicted Structure  DRACP01058

Helicity  Not available

Linear/Cyclic  Cyclic

Disulfide/Other Bond  Cys23<--->Cys28

N-terminal Modification  Free

C-terminal Modification  Free

Other Modification  None

Chiral  L



Physicochemical Information


Formula  C143H247N37O40S2

Absent amino acids  HMNQRSWY

Common amino acids  KL

Mass  372421

Pl  9.51

Basic residues  6

Acidic residues  3

Hydrophobic residues  12

Net charge  3

Boman Index  -854

Hydrophobicity  18.71

Aliphatic Index  107.1

Half Life 
  Mammalian: 30 hour
  Yeast: >20 hour
  E.coli: >10 hour

Extinction Coefficient cystines  125

Absorbance 280nm  4.17

Polar residues  9

Amino acid distribution



Literature Information


Literature 1

Pubmed ID 34073203

Title  Prediction of Anticancer Peptides with High Efficacy and Low Toxicity by Hybrid Model Based on 3D Structure of Peptides

Doi 10.3390/ijms22115630

Year  2021

Literature 2

Pubmed ID 9784389

Title  Ranatuerins: antimicrobial peptides isolated from the skin of the American bullfrog, Rana catesbeiana

Doi 10.1006/bbrc.1998.9362

Year  1998

Patent

Patent ID Not available

Patent Title  Not available

Other Iinformation  Not available

Other Published ID  Not available




DRACP is developed by Dr.Zheng's team.